We are delighted that our CIHR applications have been funded. We wish to express our gratitude to the reviewing panels and to CIHR to have kept the spring 2020 competition alive despite the COVID-19 crisis. This crucial funding will allow us to explore microbiota-targeted therapies against cancer and fight C. difficile infection.
Castagner Lab 